Topoisomerase Inhibitor [EPC]

Topoisomerase Inhibitor [EPC] was reported 76948 times

Drugs of the Topoisomerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 148 0.9673
1 THYMUS HYPOPLASIA 152 0.8736
2 HUMAN BOCAVIRUS INFECTION 133 0.7037
3 DESMOPLASTIC SMALL ROUND CELL TUMOUR 49 0.5632
4 OVARIAN GERM CELL TERATOMA 37 0.4625
5 BASAL GANGLION DEGENERATION 35 0.3723
6 NEPHROBLASTOMA 46 0.3622
7 MEDULLOBLASTOMA RECURRENT 40 0.3540
8 RENAL SALT-WASTING SYNDROME 136 0.3469
9 NEUROBLASTOMA RECURRENT 68 0.3350
10 CYSTITIS BACTERIAL 110 0.3254
11 RETINOBLASTOMA 34 0.3119
12 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 292 0.3083
13 MALIGNANT TRANSFORMATION 138 0.3073
14 NOROVIRUS TEST POSITIVE 97 0.2985
15 TERATOMA 57 0.2651
16 TREATMENT RELATED SECONDARY MALIGNANCY 53 0.2611
17 MYCOBACTERIUM CHELONAE INFECTION 184 0.2490
18 MEDULLOBLASTOMA 36 0.2416
19 DISSEMINATED ASPERGILLOSIS 114 0.2415
20 HIGH-GRADE B-CELL LYMPHOMA 45 0.2406
21 NEUROBLASTOMA 92 0.2402
22 REFRACTORY CANCER 50 0.2336
23 MENINGITIS TUBERCULOUS 125 0.2236
24 OVARIAN FAILURE 118 0.2206
25 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 483 0.2188
26 PRIMARY HYPOGONADISM 34 0.2166
27 SECONDARY IMMUNODEFICIENCY 261 0.2148
28 BLOOD STEM CELL TRANSPLANT FAILURE 45 0.2093
29 ABSCESS BACTERIAL 73 0.2011
30 OSTEOSARCOMA 76 0.1974
31 SWEAT GLAND TUMOUR 44 0.1872
32 T-CELL TYPE ACUTE LEUKAEMIA 38 0.1863
33 CAECITIS 81 0.1800
34 B-CELL LYMPHOMA RECURRENT 95 0.1750
35 HEPATOSPLENIC T-CELL LYMPHOMA 64 0.1725
36 IRIS ATROPHY 35 0.1691
37 CORONA VIRUS INFECTION 71 0.1651
38 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 38 0.1638
39 ENGRAFTMENT SYNDROME 90 0.1523
40 NEUTROPENIC INFECTION 142 0.1484
41 CENTRAL HYPOTHYROIDISM 49 0.1480
42 CONGENITAL APLASIA 46 0.1479
43 PSEUDOMONAL SEPSIS 250 0.1426
44 MANTLE CELL LYMPHOMA RECURRENT 59 0.1356
45 VENOOCCLUSIVE LIVER DISEASE 650 0.1315
46 NEUTROPENIC COLITIS 272 0.1314
47 HUMAN HERPESVIRUS 6 INFECTION 244 0.1290
48 ACUTE MYELOMONOCYTIC LEUKAEMIA 32 0.1270
49 TISSUE INFILTRATION 37 0.1254
50 PARAINFLUENZAE VIRUS INFECTION 189 0.1241
51 FEBRILE NEUTROPENIA 8088 0.1218
52 APLASIA 233 0.1189
53 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 37 0.1182
54 CYTOMEGALOVIRUS CHORIORETINITIS 230 0.1178
55 VENOOCCLUSIVE DISEASE 294 0.1173
56 CHLOROMA 49 0.1161
57 ENTEROBACTER INFECTION 191 0.1136
58 ASPERGILLUS INFECTION 730 0.1111
59 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 36 0.1098
60 MYELOID LEUKAEMIA 54 0.1078
61 NEUTROPENIC SEPSIS 761 0.1064
62 OTOTOXICITY 196 0.1059
63 VIRAL HAEMORRHAGIC CYSTITIS 74 0.1039
64 PLASMA CELL LEUKAEMIA 62 0.1033
65 VIRAEMIA 142 0.1025
66 HAEMATOTOXICITY 956 0.1005
67 STEM CELL TRANSPLANT 251 0.1004
68 AZOOSPERMIA 38 0.0990
69 KLEBSIELLA SEPSIS 111 0.0985
70 FEBRILE BONE MARROW APLASIA 418 0.0983
71 COMPLICATIONS OF BONE MARROW TRANSPLANT 35 0.0970
72 KLEBSIELLA BACTERAEMIA 92 0.0968
73 ACUTE MYELOID LEUKAEMIA 1505 0.0965
74 PSEUDOMONAL BACTERAEMIA 81 0.0948
75 MUCOSAL INFLAMMATION 2430 0.0927
76 PLASMABLASTIC LYMPHOMA 33 0.0922
77 SMALL CELL LUNG CANCER 139 0.0920
78 RADIATION OESOPHAGITIS 35 0.0919
79 FOLLICULAR LYMPHOMA 80 0.0909
80 DIFFUSE ALVEOLAR DAMAGE 104 0.0904
81 TUMOUR LYSIS SYNDROME 794 0.0902
82 ACUTE PROMYELOCYTIC LEUKAEMIA 91 0.0885
83 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 116 0.0881
84 CYSTITIS VIRAL 33 0.0862
85 MYELODYSPLASTIC SYNDROME 1234 0.0852
86 SUPERIOR VENA CAVA SYNDROME 51 0.0844
87 TRICHOSPORON INFECTION 34 0.0840
88 MINIMAL RESIDUAL DISEASE 40 0.0828
89 ENTEROCOCCAL BACTERAEMIA 87 0.0821
90 CYTOPENIA 994 0.0811
91 GRAFT VERSUS HOST DISEASE IN LIVER 58 0.0810
92 ENCEPHALITIS CYTOMEGALOVIRUS 35 0.0799
93 GASTROINTESTINAL FUNGAL INFECTION 41 0.0796
94 FUSARIUM INFECTION 55 0.0786
95 SKIN CANDIDA 41 0.0785
96 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 46 0.0776
97 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 579 0.0771
98 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 71 0.0768
99 METASTASES TO BONE MARROW 38 0.0760
100 SECOND PRIMARY MALIGNANCY 631 0.0758
101 CYSTITIS HAEMORRHAGIC 304 0.0753
102 ANGIOCENTRIC LYMPHOMA 37 0.0752
103 PLASMA CELL MYELOMA REFRACTORY 99 0.0740
104 CYTOGENETIC ABNORMALITY 83 0.0735
105 DIFFUSE LARGE B-CELL LYMPHOMA 561 0.0727
106 PULMONARY VASCULAR DISORDER 34 0.0722
107 HISTIOCYTOSIS HAEMATOPHAGIC 214 0.0720
108 SYSTEMIC MYCOSIS 84 0.0719
109 BONE MARROW TOXICITY 84 0.0709
110 STREPTOCOCCAL BACTERAEMIA 77 0.0708
111 PERIPHERAL MOTOR NEUROPATHY 99 0.0706
112 BRONCHOPULMONARY ASPERGILLOSIS 548 0.0706
113 BONE MARROW FAILURE 1436 0.0706
114 CYTOMEGALOVIRUS VIRAEMIA 312 0.0701
115 BK VIRUS INFECTION 231 0.0684
116 JC VIRUS INFECTION 109 0.0681
117 HEPATITIS B REACTIVATION 215 0.0677
118 ABDOMINAL COMPARTMENT SYNDROME 43 0.0675
119 PNEUMATOSIS INTESTINALIS 192 0.0673
120 FUNGAEMIA 103 0.0654
121 NEOPLASM RECURRENCE 221 0.0651
122 ADENOVIRUS INFECTION 187 0.0644
123 ACUTE MYELOID LEUKAEMIA RECURRENT 138 0.0642
124 ACUTE GRAFT VERSUS HOST DISEASE 280 0.0611
125 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 169 0.0611
126 ESCHERICHIA BACTERAEMIA 142 0.0603
127 ASPERGILLOSIS 78 0.0597
128 CLOSTRIDIUM DIFFICILE COLITIS 629 0.0593
129 MYELOSUPPRESSION 2134 0.0592
130 CENTRAL NERVOUS SYSTEM LYMPHOMA 81 0.0587
131 THERAPY PARTIAL RESPONDER 906 0.0580
132 BACTERIAL SEPSIS 188 0.0577
133 CLOSTRIDIUM COLITIS 70 0.0577
134 PNEUMONIA KLEBSIELLA 105 0.0571
135 CERVIX DISORDER 41 0.0569
136 FUNGAL SEPSIS 47 0.0566
137 NEUROENDOCRINE CARCINOMA 39 0.0564
138 LEUKAEMIA RECURRENT 95 0.0561
139 STENOTROPHOMONAS INFECTION 76 0.0560
140 VENA CAVA THROMBOSIS 93 0.0559
141 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 40 0.0556
142 ENTEROCOCCAL SEPSIS 45 0.0556
143 ENTEROCOCCAL INFECTION 267 0.0552
144 SYSTEMIC CANDIDA 138 0.0549
145 CYTOMEGALOVIRUS INFECTION REACTIVATION 242 0.0547
146 PNEUMOCYSTIS JIROVECI PNEUMONIA 122 0.0547
147 KLEBSIELLA INFECTION 270 0.0533
148 PANCYTOPENIA 2973 0.0531
149 GRAFT VERSUS HOST DISEASE IN SKIN 117 0.0531
150 STAPHYLOCOCCAL BACTERAEMIA 227 0.0522
151 PULMONARY VENO-OCCLUSIVE DISEASE 36 0.0514
152 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 109 0.0512
153 ACUTE LYMPHOCYTIC LEUKAEMIA 145 0.0512
154 FANCONI SYNDROME 72 0.0509
155 PULMONARY MYCOSIS 39 0.0501
156 CARDIOTOXICITY 445 0.0498
157 GASTROINTESTINAL TOXICITY 237 0.0493
158 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 87 0.0492
159 CANDIDA SEPSIS 44 0.0491
160 RHINOVIRUS INFECTION 191 0.0490
161 T-CELL LYMPHOMA 56 0.0489
162 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 69 0.0488
163 MUCORMYCOSIS 127 0.0488
164 PREMATURE MENOPAUSE 45 0.0487
165 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 41 0.0486
166 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 462 0.0484
167 PERIPHERAL SENSORY NEUROPATHY 272 0.0465
168 GENE MUTATION 90 0.0454
169 UTERINE ENLARGEMENT 36 0.0453
170 BACTERAEMIA 538 0.0453
171 CHRONIC GRAFT VERSUS HOST DISEASE 163 0.0451
172 PERIPHERAL SENSORIMOTOR NEUROPATHY 56 0.0446
173 ESCHERICHIA SEPSIS 129 0.0445
174 GASTROENTERITIS NOROVIRUS 59 0.0444
175 OESOPHAGEAL CANDIDIASIS 177 0.0444
176 AORTIC THROMBOSIS 51 0.0441
177 GRAFT VERSUS HOST DISEASE 317 0.0440
178 RENAL TUBULAR DISORDER 124 0.0440
179 TUMOUR NECROSIS 46 0.0435
180 HYPOGAMMAGLOBULINAEMIA 286 0.0435
181 EPSTEIN-BARR VIRAEMIA 48 0.0433
182 RADIATION PNEUMONITIS 92 0.0430
183 CEREBRAL TOXOPLASMOSIS 40 0.0428
184 PNEUMONIA CYTOMEGALOVIRAL 83 0.0427
185 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 110 0.0426
186 BONE MARROW DEPRESSION 41 0.0420
187 RECALL PHENOMENON 35 0.0419
188 BLOOD CULTURE POSITIVE 125 0.0417
189 CAPILLARY LEAK SYNDROME 86 0.0416
190 METASTASES TO ADRENALS 38 0.0412
191 EPSTEIN-BARR VIRUS INFECTION 257 0.0411
192 DISEASE PROGRESSION 4863 0.0411
193 ENCEPHALITIS VIRAL 50 0.0411
194 PULMONARY TOXICITY 288 0.0407
195 STREPTOCOCCAL SEPSIS 48 0.0405
196 NEUTROPENIA 5470 0.0402
197 ENTERITIS 257 0.0401
198 PNEUMONIA FUNGAL 158 0.0400
199 VARICELLA ZOSTER VIRUS INFECTION 83 0.0400
200 HEPATOSPLENOMEGALY 102 0.0397
201 THROMBOCYTOPENIA 4385 0.0392
202 NEPHROPATHY TOXIC 435 0.0387
203 VENOUS THROMBOSIS 152 0.0387
204 NEUROLOGICAL DECOMPENSATION 89 0.0384
205 THROMBOTIC MICROANGIOPATHY 374 0.0383
206 FEBRILE INFECTION 45 0.0382
207 APLASTIC ANAEMIA 199 0.0381
208 CONTINUOUS HAEMODIAFILTRATION 37 0.0378
209 SEPTIC SHOCK 1634 0.0375
210 GRANULOCYTE COUNT DECREASED 69 0.0372
211 LYMPHOPENIA 524 0.0370
212 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 187 0.0367
213 BACTERIAL INFECTION 684 0.0366
214 METASTASES TO MENINGES 83 0.0365
215 MANTLE CELL LYMPHOMA 55 0.0361
216 MYELOPATHY 68 0.0358
217 PHARYNGEAL INFLAMMATION 43 0.0354
218 ACQUIRED GENE MUTATION 46 0.0351
219 MULTIPLE ORGAN DYSFUNCTION SYNDROME 989 0.0349
220 BONE MARROW DISORDER 105 0.0347
221 NEUTROPHIL COUNT ABNORMAL 98 0.0346
222 DRUG CLEARANCE DECREASED 45 0.0344
223 METASTASES TO PERITONEUM 87 0.0344
224 BLOOD FIBRINOGEN DECREASED 39 0.0342
225 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 280 0.0339
226 LEUKOENCEPHALOPATHY 126 0.0338
227 CATHETER RELATED INFECTION 34 0.0336
228 ENCEPHALITIS AUTOIMMUNE 44 0.0335
229 CYTOMEGALOVIRUS INFECTION 556 0.0334
230 CYTOKINE RELEASE SYNDROME 666 0.0332
231 SUBILEUS 69 0.0331
232 PLASMACYTOMA 61 0.0327
233 SKIN TOXICITY 185 0.0327
234 PLATELET TRANSFUSION 42 0.0326
235 ENTEROCOLITIS 188 0.0325
236 PULMONARY HAEMORRHAGE 249 0.0318
237 HEPATITIS E 50 0.0316
238 NEUTROPHIL COUNT DECREASED 1288 0.0316
239 NEUROTOXICITY 546 0.0311
240 NEOPLASM PROGRESSION 1078 0.0310
241 STAPHYLOCOCCAL SEPSIS 153 0.0310
242 DYSPLASIA 37 0.0308
243 BICYTOPENIA 60 0.0306
244 BLOOD LACTATE DEHYDROGENASE INCREASED 478 0.0301
245 PNEUMONIA PSEUDOMONAL 46 0.0300
246 NON-HODGKIN'S LYMPHOMA 39 0.0298
247 PARAPARESIS 53 0.0297
248 INFECTION REACTIVATION 34 0.0297
249 STRONGYLOIDIASIS 48 0.0297
250 PSEUDOMONAS INFECTION 247 0.0288
251 LEUKOPENIA 1426 0.0285
252 ESCHERICHIA TEST POSITIVE 34 0.0284
253 HEPATITIS B 171 0.0283
254 SEPSIS 3133 0.0281
255 PLASMA CELL MYELOMA RECURRENT 91 0.0280
256 METASTASIS 200 0.0280
257 ACUTE RESPIRATORY DISTRESS SYNDROME 487 0.0275
258 VITREOUS HAEMORRHAGE 76 0.0275
259 HYPOALBUMINAEMIA 213 0.0274
260 B-CELL LYMPHOMA 93 0.0274
261 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 162 0.0273
262 CLOSTRIDIAL INFECTION 92 0.0272
263 HERPES SIMPLEX 174 0.0267
264 DISSEMINATED INTRAVASCULAR COAGULATION 375 0.0266
265 METASTASES TO CENTRAL NERVOUS SYSTEM 343 0.0266
266 MENINGITIS BACTERIAL 38 0.0265
267 ENCEPHALOPATHY 644 0.0262
268 METASTASES TO LYMPH NODES 175 0.0259
269 OPTIC ATROPHY 42 0.0258
270 DEAFNESS NEUROSENSORY 84 0.0255
271 LUNG CONSOLIDATION 71 0.0254
272 ARTERIAL THROMBOSIS 49 0.0253
273 PNEUMOCYSTIS JIROVECII PNEUMONIA 254 0.0253
274 OESOPHAGITIS 272 0.0249
275 MYELITIS TRANSVERSE 35 0.0248
276 QUADRIPARESIS 41 0.0247
277 LEFT VENTRICULAR DYSFUNCTION 162 0.0242
278 ENCEPHALITIS 166 0.0240
279 PNEUMOMEDIASTINUM 43 0.0238
280 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 63 0.0237
281 OVARIAN CANCER RECURRENT 38 0.0236
282 AGRANULOCYTOSIS 439 0.0236
283 RECURRENT CANCER 96 0.0235
284 CULTURE URINE POSITIVE 33 0.0235
285 PULMONARY ALVEOLAR HAEMORRHAGE 131 0.0233
286 TRAUMATIC LUNG INJURY 45 0.0233
287 CANDIDA INFECTION 393 0.0232
288 PNEUMONITIS 631 0.0232
289 JUGULAR VEIN THROMBOSIS 41 0.0230
290 HYPOMAGNESAEMIA 319 0.0229
291 NOROVIRUS INFECTION 33 0.0229
292 BONE MARROW TRANSPLANT 43 0.0227
293 MYELITIS 35 0.0226
294 TUMOUR HAEMORRHAGE 64 0.0224
295 DEVICE RELATED SEPSIS 45 0.0223
296 HYPOPHOSPHATAEMIA 165 0.0223
297 ACUTE LEUKAEMIA 36 0.0223
298 IMMUNE-MEDIATED ENTEROCOLITIS 81 0.0220
299 ESCHERICHIA INFECTION 181 0.0220
300 MALIGNANT NEOPLASM PROGRESSION 2252 0.0220
301 GASTROINTESTINAL NECROSIS 64 0.0219
302 LUNG INFILTRATION 193 0.0218
303 HYPOPITUITARISM 38 0.0218
304 MENINGITIS CRYPTOCOCCAL 38 0.0217
305 SYSTEMIC INFECTION 36 0.0217
306 DRUG RESISTANCE 556 0.0216
307 SERUM FERRITIN INCREASED 114 0.0216
308 AUTOIMMUNE HAEMOLYTIC ANAEMIA 74 0.0216
309 LYMPHOMA 332 0.0215
310 SMALL INTESTINAL PERFORATION 40 0.0213
311 SOFT TISSUE INFECTION 39 0.0213
312 CYTOMEGALOVIRUS COLITIS 49 0.0213
313 HYPERTRANSAMINASAEMIA 147 0.0211
314 HYPERBILIRUBINAEMIA 218 0.0210
315 OSTEOLYSIS 43 0.0210
316 POLYNEUROPATHY 251 0.0209
317 MALIGNANT PLEURAL EFFUSION 35 0.0207
318 METASTASES TO LUNG 238 0.0206
319 FANCONI SYNDROME ACQUIRED 36 0.0205
320 HEPATOTOXICITY 445 0.0200
321 INTRACARDIAC THROMBUS 61 0.0199
322 CYTOMEGALOVIRUS TEST POSITIVE 35 0.0196
323 PAPILLARY THYROID CANCER 34 0.0195
324 DIABETES INSIPIDUS 47 0.0195
325 LOBAR PNEUMONIA 36 0.0194
326 QUADRIPLEGIA 40 0.0194
327 ANAEMIA 3689 0.0193
328 MULTI-ORGAN FAILURE 329 0.0190
329 RESPIRATORY FAILURE 1386 0.0190
330 HYPOPROTEINAEMIA 36 0.0190
331 TOXIC ENCEPHALOPATHY 96 0.0189
332 HYDROCEPHALUS 103 0.0189
333 STREPTOCOCCAL INFECTION 105 0.0189
334 LYMPHADENOPATHY MEDIASTINAL 36 0.0188
335 DRUG TOXICITY 254 0.0186
336 ILEUS 230 0.0185
337 GROWTH RETARDATION 54 0.0183
338 HYPERURICAEMIA 75 0.0182
339 ELECTROLYTE IMBALANCE 212 0.0182
340 DISEASE RECURRENCE 867 0.0182
341 EMBOLISM VENOUS 54 0.0178
342 HYPERPHOSPHATAEMIA 38 0.0177
343 LUNG ABSCESS 37 0.0176
344 HYPOKALAEMIA 813 0.0176
345 COLITIS 666 0.0176
346 TRANSPLANT FAILURE 43 0.0175
347 CORONARY ARTERY THROMBOSIS 35 0.0173
348 EMBOLISM 143 0.0172
349 HAEMODYNAMIC INSTABILITY 131 0.0172
350 CARDIOMYOPATHY 254 0.0172
351 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 176 0.0171
352 FUNGAL INFECTION 570 0.0171
353 HYDRONEPHROSIS 128 0.0171
354 BRAIN HERNIATION 51 0.0171
355 FOETAL GROWTH RESTRICTION 103 0.0169
356 EJECTION FRACTION DECREASED 262 0.0168
357 METASTASES TO LIVER 296 0.0168
358 CARDIAC TAMPONADE 80 0.0168
359 ODYNOPHAGIA 100 0.0167
360 ADRENAL INSUFFICIENCY 203 0.0167
361 GRANULOCYTOPENIA 95 0.0167
362 IMMUNE-MEDIATED HEPATITIS 34 0.0166
363 URINARY TRACT INFECTION BACTERIAL 42 0.0166
364 MULTIPLE-DRUG RESISTANCE 51 0.0164
365 HYPERTRIGLYCERIDAEMIA 94 0.0160
366 HYPERNATRAEMIA 80 0.0160
367 LYMPHOPROLIFERATIVE DISORDER 47 0.0160
368 CANDIDIASIS 64 0.0159
369 CLOSTRIDIUM TEST POSITIVE 35 0.0159
370 RETINAL HAEMORRHAGE 113 0.0158
371 PLATELET DISORDER 40 0.0158
372 MATERNAL EXPOSURE BEFORE PREGNANCY 108 0.0158
373 GASTROINTESTINAL INFLAMMATION 123 0.0157
374 DYSAESTHESIA 48 0.0156
375 RETINOPATHY 58 0.0155
376 PLASMA CELL MYELOMA 606 0.0155
377 GUILLAIN-BARRE SYNDROME 75 0.0155
378 DEVICE RELATED INFECTION 237 0.0154
379 ABDOMINAL MASS 41 0.0153
380 FIBROSIS 47 0.0153
381 THERAPY NON-RESPONDER 682 0.0152
382 METASTATIC NEOPLASM 65 0.0151
383 ASCITES 442 0.0150
384 VENTRICULAR DYSFUNCTION 39 0.0150
385 LYMPHADENOPATHY 531 0.0150
386 WHITE BLOOD CELL DISORDER 40 0.0149
387 COVID-19 PNEUMONIA 175 0.0148
388 HYPOCALCAEMIA 280 0.0148
389 INFECTION 2138 0.0148
390 VASCULAR DEVICE INFECTION 67 0.0148
391 PNEUMONIA BACTERIAL 135 0.0147
392 STOMATITIS 892 0.0147
393 ATELECTASIS 142 0.0147
394 VENTRICULAR HYPOKINESIA 47 0.0146
395 PLATELET COUNT DECREASED 1555 0.0146
396 ILEUS PARALYTIC 65 0.0145
397 PNEUMOTHORAX 227 0.0143
398 THROMBOPHLEBITIS 50 0.0142
399 GASTROINTESTINAL PERFORATION 59 0.0142
400 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 33 0.0142
401 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 54 0.0141
402 RESPIRATORY SYNCYTIAL VIRUS INFECTION 123 0.0141
403 PNEUMONIA VIRAL 45 0.0141
404 NOCARDIOSIS 36 0.0141
405 PANNICULITIS 34 0.0140
406 HYPOVOLAEMIC SHOCK 67 0.0140
407 METASTASES TO SPINE 47 0.0140
408 SUSPECTED OFF LABEL USE 63 0.0139
409 HYPERPYREXIA 59 0.0139
410 SUBDURAL HAEMORRHAGE 38 0.0139
411 HAEMOGLOBIN ABNORMAL 89 0.0138
412 PAPILLOEDEMA 62 0.0137
413 INTESTINAL PERFORATION 154 0.0137
414 CARDIAC DYSFUNCTION 51 0.0137
415 LYMPHOCYTE COUNT DECREASED 242 0.0137
416 SPLENOMEGALY 160 0.0136
417 HEPATIC LESION 59 0.0136
418 CACHEXIA 70 0.0136
419 CARDIOPULMONARY FAILURE 53 0.0136
420 AREFLEXIA 36 0.0135
421 ACUTE HEPATIC FAILURE 184 0.0135
422 RESPIRATORY DISTRESS 369 0.0134
423 LUNG NEOPLASM 57 0.0133
424 CHRONIC SINUSITIS 50 0.0133
425 AMYLASE INCREASED 49 0.0133
426 LARGE INTESTINE PERFORATION 92 0.0132
427 HYPOXIA 466 0.0132
428 NEOPLASM 152 0.0132
429 CHRONIC MYELOID LEUKAEMIA 61 0.0132
430 WHITE BLOOD CELL COUNT ABNORMAL 84 0.0131
431 HEPATITIS FULMINANT 39 0.0131
432 MENINGITIS ASEPTIC 59 0.0131
433 BLOOD BILIRUBIN INCREASED 355 0.0131
434 EXTRAVASATION 54 0.0131
435 ORGANISING PNEUMONIA 65 0.0131
436 STAPHYLOCOCCAL INFECTION 432 0.0131
437 HEPATIC FAILURE 394 0.0131
438 WHITE BLOOD CELL COUNT DECREASED 1412 0.0130
439 DERMATOMYOSITIS 33 0.0130
440 CONGESTIVE CARDIOMYOPATHY 54 0.0129
441 PRODUCT USE IN UNAPPROVED INDICATION 3209 0.0129
442 ACUTE RESPIRATORY FAILURE 249 0.0129
443 IMMUNOSUPPRESSION 114 0.0129
444 PLATELET COUNT ABNORMAL 78 0.0129
445 PERICARDIAL EFFUSION 297 0.0128
446 HYPOTHYROIDISM 408 0.0128
447 NEUROPATHY PERIPHERAL 1202 0.0126
448 HYPERCAPNIA 38 0.0126
449 LUNG OPACITY 33 0.0125
450 LEUKAEMIA 118 0.0125
451 MYOSITIS 112 0.0125
452 BONE LESION 45 0.0125
453 HEPATIC NECROSIS 47 0.0125
454 CLOSTRIDIUM DIFFICILE INFECTION 271 0.0124
455 PLEURAL EFFUSION 753 0.0124
456 SMALL INTESTINAL OBSTRUCTION 152 0.0123
457 LIVER ABSCESS 40 0.0123
458 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 669 0.0122
459 HAEMODIALYSIS 102 0.0121
460 PARAPLEGIA 35 0.0121
461 SHOCK HAEMORRHAGIC 98 0.0120
462 VIRAL INFECTION 400 0.0120
463 HEPATOMEGALY 117 0.0119
464 MALNUTRITION 133 0.0119
465 DERMATITIS EXFOLIATIVE GENERALISED 41 0.0118
466 MONOPLEGIA 51 0.0117
467 HYPERVOLAEMIA 58 0.0117
468 METASTASES TO BONE 192 0.0117
469 TACHYPNOEA 159 0.0117
470 ABDOMINAL TENDERNESS 58 0.0117
471 HERPES VIRUS INFECTION 67 0.0116
472 HYPONATRAEMIA 653 0.0116
473 PERFORMANCE STATUS DECREASED 54 0.0116
474 OLIGURIA 71 0.0114
475 ACUTE PULMONARY OEDEMA 64 0.0114
476 HAEMOTHORAX 33 0.0114
477 IMMUNE THROMBOCYTOPENIA 52 0.0113
478 NECROSIS 63 0.0113
479 ESCHERICHIA URINARY TRACT INFECTION 48 0.0113
480 HEPATIC CYST 38 0.0112
481 STRESS CARDIOMYOPATHY 65 0.0112
482 APPENDICITIS 104 0.0111
483 HYPOVOLAEMIA 65 0.0111
484 INTERSTITIAL LUNG DISEASE 537 0.0111
485 METABOLIC DISORDER 64 0.0110
486 LUNG ADENOCARCINOMA 33 0.0110
487 PYELONEPHRITIS 95 0.0110
488 TRANSAMINASES INCREASED 242 0.0109
489 BRAIN OEDEMA 137 0.0108
490 HEPATIC FUNCTION ABNORMAL 402 0.0108
491 PYREXIA 3727 0.0108
492 RENAL TUBULAR NECROSIS 104 0.0106
493 TRANSFUSION 111 0.0106
494 OPTIC ISCHAEMIC NEUROPATHY 41 0.0106
495 ALANINE AMINOTRANSFERASE INCREASED 645 0.0105
496 MYOCARDITIS 120 0.0105
497 BLOOD ALBUMIN DECREASED 83 0.0105
498 HEARING IMPAIRED 62 0.0103
499 COAGULOPATHY 171 0.0103
500 URINE OUTPUT DECREASED 89 0.0102
501 MYOPATHY 87 0.0101
502 RENAL FAILURE ACUTE 427 0.0101
503 PULMONARY FIBROSIS 193 0.0101
504 CARDIAC FAILURE ACUTE 67 0.0100
505 LUNG INFECTION 156 0.0100
506 HAEMORRHAGE INTRACRANIAL 150 0.0100
507 FAILURE TO THRIVE 52 0.0100
508 OFF LABEL USE 8763 0.0100
509 DEAFNESS 260 0.0099
510 NECROTISING FASCIITIS 35 0.0099
511 INFLAMMATORY MARKER INCREASED 49 0.0099
512 UROSEPSIS 91 0.0099
513 SINUS TACHYCARDIA 139 0.0098
514 SUBARACHNOID HAEMORRHAGE 99 0.0097
515 SUPRAVENTRICULAR TACHYCARDIA 93 0.0097
516 CONJUNCTIVAL HAEMORRHAGE 37 0.0097
517 MULTIPLE MYELOMA 45 0.0096
518 HYPERAMMONAEMIA 48 0.0096
519 ARTHRITIS BACTERIAL 39 0.0095
520 MOUTH ULCERATION 200 0.0095
521 C-REACTIVE PROTEIN INCREASED 345 0.0095
522 ENDOCARDITIS 48 0.0093
523 CEREBRAL ATROPHY 37 0.0093
524 CHRONIC LYMPHOCYTIC LEUKAEMIA 44 0.0093
525 ORAL CANDIDIASIS 122 0.0093
526 NON-SMALL CELL LUNG CANCER 44 0.0092
527 PROCTALGIA 59 0.0092
528 ABSCESS LIMB 39 0.0091
529 HEPATITIS CHOLESTATIC 55 0.0091
530 GENERALISED OEDEMA 112 0.0090
531 NERVOUS SYSTEM DISORDER 282 0.0090
532 NO THERAPEUTIC RESPONSE 110 0.0090
533 ATAXIA 107 0.0090
534 LIPASE INCREASED 69 0.0090
535 ACUTE KIDNEY INJURY 1374 0.0090
536 ORAL HERPES 175 0.0090
537 HEPATIC ENCEPHALOPATHY 83 0.0089
538 BRONCHOSPASM 126 0.0088
539 PARTIAL SEIZURES 46 0.0088
540 ASPARTATE AMINOTRANSFERASE INCREASED 464 0.0087
541 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 44 0.0087
542 STATUS EPILEPTICUS 98 0.0087
543 HEMIPARESIS 146 0.0086
544 INGUINAL HERNIA 52 0.0085
545 MENINGITIS 56 0.0084
546 ACIDOSIS 64 0.0084
547 RENAL IMPAIRMENT 702 0.0083
548 SKIN NECROSIS 43 0.0083
549 SARCOIDOSIS 39 0.0082
550 LOW BIRTH WEIGHT BABY 65 0.0082
551 PNEUMONIA 2624 0.0081
552 CARDIAC FAILURE 650 0.0081
553 MENTAL STATUS CHANGES 224 0.0081
554 RESPIRATORY TRACT INFECTION 210 0.0081
555 ATRIAL FIBRILLATION 785 0.0081
556 HYPERCALCAEMIA 99 0.0080
557 INTESTINAL ISCHAEMIA 44 0.0080
558 RENAL FAILURE 1058 0.0080
559 INTERVERTEBRAL DISC DISORDER 34 0.0080
560 BLOOD CREATINE INCREASED 35 0.0079
561 DEEP VEIN THROMBOSIS 513 0.0079
562 HYPERGLYCAEMIA 282 0.0077
563 CELLULITIS 389 0.0077
564 CORONAVIRUS INFECTION 51 0.0077
565 NEUROLOGICAL SYMPTOM 44 0.0077
566 PROTHROMBIN TIME PROLONGED 46 0.0077
567 HAEMOPTYSIS 214 0.0077
568 ATRIAL FLUTTER 61 0.0076
569 BLOOD DISORDER 61 0.0076
570 RASH MACULO-PAPULAR 169 0.0076
571 CEREBRAL ISCHAEMIA 39 0.0076
572 LEUKOCYTOSIS 136 0.0075
573 ACUTE CORONARY SYNDROME 62 0.0075
574 HAEMOLYTIC ANAEMIA 67 0.0075
575 PROTEINURIA 141 0.0074
576 CEREBRAL INFARCTION 181 0.0074
577 OVARIAN CANCER 68 0.0074
578 GAMMA-GLUTAMYLTRANSFERASE INCREASED 163 0.0073
579 TACHYCARDIA 650 0.0073
580 BLOOD CREATININE INCREASED 475 0.0073
581 PURPURA 64 0.0072
582 HAEMOGLOBIN DECREASED 741 0.0072
583 ANURIA 62 0.0072
584 TUBULOINTERSTITIAL NEPHRITIS 135 0.0072
585 TOXICITY TO VARIOUS AGENTS 1208 0.0072
586 CEREBRAL HAEMORRHAGE 255 0.0071
587 HYPERTHYROIDISM 103 0.0071
588 RENAL CYST 56 0.0070
589 TOXIC SKIN ERUPTION 71 0.0070
590 PULMONARY EMBOLISM 666 0.0070
591 SHOCK 161 0.0070
592 OSTEONECROSIS 229 0.0070
593 TONSILLITIS 36 0.0069
594 BLOOD UREA INCREASED 115 0.0069
595 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 34 0.0068
596 PULMONARY OEDEMA 305 0.0068
597 ANGIOPATHY 38 0.0068
598 HAEMATURIA 232 0.0068
599 HEPATOCELLULAR INJURY 96 0.0068
600 BLOOD ALKALINE PHOSPHATASE INCREASED 168 0.0068
601 HERPES ZOSTER 387 0.0067
602 SUBDURAL HAEMATOMA 96 0.0067
603 HICCUPS 55 0.0067
604 HYPERTHERMIA 51 0.0067
605 TREATMENT FAILURE 553 0.0067
606 ASPIRATION 73 0.0067
607 NEUTROPHIL COUNT INCREASED 68 0.0066
608 INTRACRANIAL PRESSURE INCREASED 37 0.0066
609 DERMATITIS EXFOLIATIVE 33 0.0066
610 CIRCULATORY COLLAPSE 112 0.0066
611 GENERAL PHYSICAL HEALTH DETERIORATION 757 0.0065
612 PULMONARY ARTERIAL HYPERTENSION 94 0.0065
613 PATHOGEN RESISTANCE 59 0.0065
614 HEPATITIS 165 0.0064
615 ACUTE MYOCARDIAL INFARCTION 190 0.0064
616 PULMONARY HYPERTENSION 133 0.0064
617 LIVER DISORDER 280 0.0063
618 CHOLESTASIS 121 0.0063
619 NEPHROTIC SYNDROME 43 0.0063
620 HEMIPLEGIA 52 0.0062
621 PETECHIAE 65 0.0062
622 MASS 86 0.0061
623 LUNG DISORDER 301 0.0061
624 BLOOD MAGNESIUM DECREASED 53 0.0061
625 CHOLECYSTITIS 73 0.0061
626 ANAL ABSCESS 33 0.0061
627 BLOOD URIC ACID INCREASED 35 0.0061
628 HYPOTENSION 1207 0.0060
629 MITRAL VALVE INCOMPETENCE 68 0.0060
630 CHOLECYSTITIS ACUTE 34 0.0060
631 RESPIRATORY DISORDER 179 0.0060
632 PLATELET COUNT INCREASED 78 0.0060
633 CHOLANGITIS 37 0.0060
634 CENTRAL NERVOUS SYSTEM LESION 82 0.0060
635 HAEMATOCRIT DECREASED 117 0.0059
636 SINUS BRADYCARDIA 57 0.0059
637 HYPOPHAGIA 150 0.0059
638 HYPERVENTILATION 34 0.0059
639 SUDDEN DEATH 62 0.0059
640 FLUID OVERLOAD 85 0.0058
641 TYPE 1 DIABETES MELLITUS 35 0.0058
642 EYELID PTOSIS 59 0.0058
643 ABSCESS 92 0.0058
644 ANOREXIA 74 0.0057
645 INTENTIONAL PRODUCT USE ISSUE 499 0.0057
646 PULMONARY MASS 84 0.0056
647 FACIAL PARALYSIS 48 0.0056
648 HYPOTONIA 56 0.0056
649 PERICARDITIS 94 0.0056
650 HAEMORRHAGE 579 0.0055
651 MYOCARDIAL ISCHAEMIA 63 0.0055
652 TOXIC EPIDERMAL NECROLYSIS 84 0.0055
653 PROCEDURAL COMPLICATION 42 0.0055
654 SPINAL PAIN 64 0.0055
655 GASTROINTESTINAL HAEMORRHAGE 455 0.0054
656 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 126 0.0054
657 HEPATITIS ACUTE 35 0.0054
658 DEHYDRATION 713 0.0053
659 BODY TEMPERATURE INCREASED 109 0.0053
660 LIVER INJURY 131 0.0053
661 INFUSION RELATED REACTION 350 0.0053
662 PULMONARY CONGESTION 69 0.0052
663 PRODUCT PRESCRIBING ISSUE 114 0.0052
664 VOMITING 2441 0.0052
665 ORAL DISORDER 38 0.0052
666 MOUTH HAEMORRHAGE 38 0.0052
667 CARDIOGENIC SHOCK 74 0.0052
668 CYANOSIS 81 0.0051
669 GASTROINTESTINAL INFECTION 46 0.0051
670 DERMATITIS BULLOUS 37 0.0051
671 DRUG-INDUCED LIVER INJURY 160 0.0051
672 GRAND MAL CONVULSION 47 0.0051
673 SKIN INFECTION 57 0.0051
674 ALTERED STATE OF CONSCIOUSNESS 107 0.0049
675 APHASIA 149 0.0049
676 GASTROENTERITIS 71 0.0049
677 DRUG ERUPTION 86 0.0048
678 JAUNDICE 130 0.0048
679 DYSPHAGIA 458 0.0048
680 UPPER GASTROINTESTINAL HAEMORRHAGE 81 0.0048
681 RENAL FAILURE CHRONIC 37 0.0048
682 PANCREATITIS ACUTE 108 0.0048
683 TRICUSPID VALVE INCOMPETENCE 38 0.0048
684 VENTRICULAR FIBRILLATION 53 0.0048
685 OXYGEN SATURATION DECREASED 268 0.0048
686 METABOLIC ACIDOSIS 152 0.0047
687 PREMATURE BABY 143 0.0047
688 CARDIAC ARREST 392 0.0047
689 EYELID OEDEMA 55 0.0047
690 RESPIRATORY RATE INCREASED 42 0.0047
691 PREMATURE DELIVERY 75 0.0047
692 FLANK PAIN 44 0.0047
693 HAEMOLYSIS 36 0.0047
694 NEPHROPATHY 43 0.0046
695 DERMATITIS 96 0.0046
696 ANAPHYLACTIC REACTION 253 0.0046
697 HAEMATEMESIS 116 0.0046
698 BLOOD SODIUM DECREASED 86 0.0046
699 ORAL PAIN 102 0.0046
700 MELAENA 99 0.0045
701 DIARRHOEA HAEMORRHAGIC 42 0.0045
702 ISCHAEMIC STROKE 80 0.0045
703 GENERALISED TONIC-CLONIC SEIZURE 74 0.0045
704 HYPERKALAEMIA 156 0.0044
705 EPISTAXIS 332 0.0044
706 PRODUCT USE ISSUE 832 0.0044
707 THERAPEUTIC RESPONSE DECREASED 266 0.0044
708 CONVULSION 250 0.0044
709 IMMUNODEFICIENCY 65 0.0044
710 DISORIENTATION 171 0.0043
711 PERITONITIS 89 0.0043
712 CYSTITIS 136 0.0043
713 DEPRESSED LEVEL OF CONSCIOUSNESS 168 0.0042
714 RETINAL DETACHMENT 39 0.0042
715 HEPATIC STEATOSIS 79 0.0042
716 ABDOMINAL PAIN 984 0.0042
717 INFLAMMATION 218 0.0042
718 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 300 0.0042
719 WHITE BLOOD CELL COUNT INCREASED 161 0.0042
720 BASAL CELL CARCINOMA 65 0.0042
721 SKIN LESION 114 0.0042
722 CARDIOMEGALY 51 0.0041
723 ORTHOSTATIC HYPOTENSION 72 0.0041
724 TENDERNESS 43 0.0041
725 DECREASED APPETITE 957 0.0041
726 BONE PAIN 241 0.0041
727 OEDEMA 223 0.0041
728 PHARYNGITIS 51 0.0041
729 MOTOR DYSFUNCTION 41 0.0040
730 CARDIO-RESPIRATORY ARREST 167 0.0040
731 RED BLOOD CELL COUNT DECREASED 113 0.0039
732 DIPLOPIA 102 0.0039
733 PNEUMONIA ASPIRATION 98 0.0039
734 BLOOD CALCIUM DECREASED 44 0.0039
735 SEIZURE 450 0.0039
736 BRADYCARDIA 206 0.0039
737 HAEMATOMA 100 0.0039
738 INTESTINAL OBSTRUCTION 145 0.0038
739 NEURALGIA 93 0.0038
740 THYROID CANCER 46 0.0038
741 COMA 182 0.0038
742 AMENORRHOEA 67 0.0038
743 DIARRHOEA 2464 0.0038
744 HEPATIC CYTOLYSIS 48 0.0038
745 CHILLS 440 0.0037
746 ERYTHEMA MULTIFORME 35 0.0037
747 DRUG INEFFECTIVE 4931 0.0037
748 EPILEPSY 114 0.0037
749 FULL BLOOD COUNT DECREASED 75 0.0037
750 PRODUCTIVE COUGH 177 0.0037
751 DRUG INTOLERANCE 357 0.0037
752 SENSORY DISTURBANCE 59 0.0037
753 EMPHYSEMA 37 0.0037
754 CONSTIPATION 795 0.0036
755 DELIRIUM 126 0.0036
756 BLOOD POTASSIUM DECREASED 109 0.0036
757 VASCULITIS 42 0.0036
758 NIGHT SWEATS 116 0.0036
759 INCONTINENCE 38 0.0036
760 CONFUSIONAL STATE 579 0.0036
761 IMMUNE SYSTEM DISORDER 47 0.0036
762 GASTRIC HAEMORRHAGE 41 0.0036
763 GASTROINTESTINAL DISORDER 318 0.0035
764 RED BLOOD CELL SEDIMENTATION RATE INCREASED 39 0.0035
765 RESPIRATORY DEPRESSION 43 0.0035
766 DEATH 3018 0.0035
767 NAUSEA 2770 0.0035
768 UNRESPONSIVE TO STIMULI 90 0.0035
769 DYSPNOEA EXERTIONAL 130 0.0034
770 URINARY RETENTION 115 0.0034
771 ARRHYTHMIA 163 0.0034
772 OBSTRUCTIVE AIRWAYS DISORDER 38 0.0034
773 SYNCOPE 341 0.0034
774 CONDITION AGGRAVATED 1029 0.0034
775 VENTRICULAR EXTRASYSTOLES 35 0.0034
776 ASTHENIA 1266 0.0034
777 HYPOTHERMIA 34 0.0034
778 BLINDNESS 136 0.0033
779 ANAPHYLACTIC SHOCK 86 0.0033
780 HYPOKINESIA 48 0.0033
781 COVID-19 578 0.0033
782 DRUG INTERACTION 521 0.0033
783 DIALYSIS 46 0.0032
784 DRUG EFFECT INCOMPLETE 117 0.0032
785 MUSCULAR WEAKNESS 366 0.0032
786 LIVER FUNCTION TEST ABNORMAL 93 0.0032
787 UPPER RESPIRATORY TRACT INFECTION 147 0.0032
788 TINNITUS 146 0.0032
789 HYPERTENSION 667 0.0031
790 ILL-DEFINED DISORDER 189 0.0031
791 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 53 0.0031
792 VENTRICULAR TACHYCARDIA 51 0.0031
793 PARALYSIS 44 0.0031
794 COGNITIVE DISORDER 142 0.0030
795 PANCREATITIS 160 0.0030
796 HAEMORRHOIDS 59 0.0030
797 DRUG LEVEL INCREASED 50 0.0030
798 DYSPNOEA 1703 0.0030
799 FEEDING DISORDER 60 0.0030
800 FLUSHING 296 0.0029
801 OEDEMA PERIPHERAL 351 0.0029
802 OSTEOMYELITIS 52 0.0029
803 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 84 0.0029
804 RENAL DISORDER 133 0.0029
805 GASTRITIS 75 0.0028
806 RECTAL HAEMORRHAGE 122 0.0028
807 PALLOR 76 0.0028
808 COUGH 783 0.0028
809 URINARY TRACT INFECTION 476 0.0028
810 LETHARGY 157 0.0027
811 LOWER RESPIRATORY TRACT INFECTION 124 0.0027
812 DYSARTHRIA 102 0.0027
813 NEOPLASM MALIGNANT 180 0.0027
814 SKIN ULCER 69 0.0027
815 HEPATIC ENZYME INCREASED 181 0.0027
816 MATERNAL EXPOSURE DURING PREGNANCY 236 0.0026
817 OBESITY 42 0.0026
818 ABDOMINAL PAIN LOWER 66 0.0026
819 MUSCULOSKELETAL CHEST PAIN 40 0.0026
820 THROMBOSIS 207 0.0026
821 FOETAL EXPOSURE DURING PREGNANCY 206 0.0025
822 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0025
823 DIVERTICULITIS 69 0.0025
824 DYSURIA 91 0.0025
825 PSYCHOTIC DISORDER 73 0.0025
826 RESPIRATORY ARREST 68 0.0025
827 EATING DISORDER 52 0.0024
828 SKIN DISORDER 81 0.0024
829 ALOPECIA 467 0.0024
830 HYPOACUSIS 102 0.0024
831 PELVIC PAIN 43 0.0024
832 PRESYNCOPE 57 0.0023
833 ELECTROCARDIOGRAM QT PROLONGED 84 0.0023
834 CHEST PAIN 426 0.0023
835 STEVENS-JOHNSON SYNDROME 51 0.0023
836 CHEST DISCOMFORT 234 0.0023
837 LIVER FUNCTION TEST INCREASED 49 0.0023
838 BLOOD POTASSIUM INCREASED 37 0.0023
839 CONJUNCTIVITIS 42 0.0023
840 RHABDOMYOLYSIS 94 0.0023
841 FACE OEDEMA 38 0.0023
842 BLOOD PRESSURE DECREASED 149 0.0022
843 URINARY INCONTINENCE 66 0.0022
844 RASH ERYTHEMATOUS 106 0.0022
845 CARDIAC FAILURE CONGESTIVE 178 0.0022
846 GASTRIC ULCER 42 0.0022
847 SLEEP APNOEA SYNDROME 42 0.0022
848 LUNG NEOPLASM MALIGNANT 90 0.0022
849 FATIGUE 1693 0.0022
850 OROPHARYNGEAL PAIN 200 0.0022
851 ABDOMINAL DISTENSION 224 0.0021
852 ERYTHEMA 441 0.0021
853 POST PROCEDURAL COMPLICATION 41 0.0021
854 WEIGHT DECREASED 593 0.0021
855 BLOOD TRIGLYCERIDES INCREASED 37 0.0021
856 DIABETIC KETOACIDOSIS 50 0.0021
857 ANGINA PECTORIS 59 0.0021
858 BACK PAIN 472 0.0020
859 MUSCULOSKELETAL PAIN 104 0.0020
860 CARDIOVASCULAR DISORDER 49 0.0019
861 LACTIC ACIDOSIS 62 0.0019
862 EAR PAIN 36 0.0018
863 SPEECH DISORDER 96 0.0018
864 LOSS OF CONSCIOUSNESS 232 0.0018
865 BLOOD CREATINE PHOSPHOKINASE INCREASED 52 0.0018
866 PARAESTHESIA 284 0.0018
867 SINUSITIS 185 0.0018
868 TOOTH DISORDER 40 0.0018
869 HYPOAESTHESIA 267 0.0018
870 LABORATORY TEST ABNORMAL 51 0.0017
871 VAGINAL HAEMORRHAGE 75 0.0017
872 TRANSIENT ISCHAEMIC ATTACK 58 0.0017
873 RHINORRHOEA 111 0.0017
874 RENAL INJURY 51 0.0017
875 EXPOSURE DURING PREGNANCY 106 0.0017
876 PAIN IN JAW 48 0.0017
877 HYPOGLYCAEMIA 82 0.0017
878 RASH 733 0.0017
879 AGITATION 123 0.0017
880 INFLUENZA 177 0.0016
881 CHOLELITHIASIS 52 0.0016
882 HYPERSENSITIVITY 293 0.0016
883 CARDIAC DISORDER 146 0.0016
884 CHRONIC KIDNEY DISEASE 117 0.0015
885 GASTRIC CANCER 38 0.0015
886 THROAT TIGHTNESS 40 0.0015
887 HEART RATE INCREASED 146 0.0015
888 DISTURBANCE IN ATTENTION 79 0.0015
889 RESTLESSNESS 53 0.0014
890 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 75 0.0014
891 DYSPHONIA 84 0.0014
892 LIP SWELLING 46 0.0014
893 PAIN IN EXTREMITY 406 0.0014
894 SOMNOLENCE 273 0.0014
895 VISUAL ACUITY REDUCED 45 0.0014
896 WHEEZING 80 0.0013
897 HEADACHE 844 0.0013
898 NECK PAIN 75 0.0013
899 HAEMATOCHEZIA 72 0.0013
900 DYSPEPSIA 128 0.0013
901 MYOCARDIAL INFARCTION 226 0.0013
902 CATARACT 77 0.0013
903 MYALGIA 219 0.0013
904 HYPERHIDROSIS 164 0.0013
905 BRONCHITIS 94 0.0013
906 CONTRAINDICATED PRODUCT ADMINISTERED 38 0.0013
907 DYSGEUSIA 93 0.0013
908 CEREBROVASCULAR ACCIDENT 207 0.0012
909 TYPE 2 DIABETES MELLITUS 41 0.0012
910 DIZZINESS 606 0.0012
911 SWELLING FACE 77 0.0012
912 RASH PRURITIC 64 0.0012
913 MOBILITY DECREASED 84 0.0012
914 ADVERSE EVENT 107 0.0012
915 BLISTER 65 0.0012
916 ABDOMINAL PAIN UPPER 233 0.0011
917 POLLAKIURIA 47 0.0011
918 MOVEMENT DISORDER 36 0.0011
919 PAIN 688 0.0011
920 BALANCE DISORDER 95 0.0011
921 TREMOR 182 0.0011
922 IMPAIRED HEALING 36 0.0011
923 HALLUCINATION 82 0.0011
924 ANGIOEDEMA 48 0.0011
925 OSTEOPOROSIS 44 0.0011
926 FEMUR FRACTURE 33 0.0011
927 GAIT DISTURBANCE 203 0.0011
928 VERTIGO 64 0.0010
929 VISUAL IMPAIRMENT 129 0.0010
930 THERAPEUTIC PRODUCT EFFECT DECREASED 46 0.0010
931 NO ADVERSE EVENT 184 0.0010
932 TREATMENT NONCOMPLIANCE 53 0.0010
933 DIABETES MELLITUS 73 0.0010
934 FALL 318 0.0010
935 FLUID RETENTION 48 0.0009
936 SWELLING 88 0.0009
937 HEART RATE DECREASED 33 0.0009
938 MALAISE 412 0.0009
939 SKIN EXFOLIATION 79 0.0009
940 FEELING HOT 57 0.0009
941 UNEVALUABLE EVENT 70 0.0009
942 PALPITATIONS 107 0.0009
943 ARTHRALGIA 366 0.0009
944 MENTAL DISORDER 38 0.0009
945 DEPRESSION 198 0.0009
946 MEDICATION ERROR 47 0.0008
947 DYSKINESIA 34 0.0008
948 PRURITUS 319 0.0008
949 SKIN DISCOLOURATION 37 0.0008
950 BLOOD PRESSURE INCREASED 120 0.0008
951 OCULAR HYPERAEMIA 36 0.0008
952 VISION BLURRED 104 0.0008
953 DISCOMFORT 46 0.0008
954 WEIGHT INCREASED 166 0.0007
955 SLEEP DISORDER 52 0.0007
956 IRRITABILITY 41 0.0007
957 ABDOMINAL DISCOMFORT 111 0.0007
958 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
959 MEMORY IMPAIRMENT 90 0.0007
960 DRY MOUTH 53 0.0007
961 AMNESIA 42 0.0006
962 MUSCLE SPASMS 118 0.0006
963 PROSTATE CANCER 49 0.0006
964 CONTUSION 58 0.0006
965 FLATULENCE 34 0.0006
966 ANXIETY 157 0.0006
967 DEVICE MALFUNCTION 38 0.0005
968 INJECTION SITE REACTION 37 0.0005
969 INSOMNIA 140 0.0005
970 URTICARIA 86 0.0005
971 ADVERSE DRUG REACTION 46 0.0005
972 BLOOD GLUCOSE INCREASED 96 0.0005
973 ARTHRITIS 40 0.0005
974 PERIPHERAL SWELLING 77 0.0005
975 HOSPITALISATION 74 0.0005
976 HOT FLUSH 35 0.0005
977 DRY SKIN 61 0.0005
978 DRUG ABUSE 38 0.0005
979 BREAST CANCER 37 0.0004
980 OVERDOSE 84 0.0004
981 EMOTIONAL DISTRESS 42 0.0003
982 MIGRAINE 33 0.0003
983 FEELING ABNORMAL 76 0.0003
984 NASOPHARYNGITIS 54 0.0003
985 PSORIASIS 36 0.0003
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002